Skip to content
GLP-1 Scorecard
Menu
Graded #524

WeightCare

WeightCare offers compounded semaglutide ($249–$399/mo) and tirzepatide ($349/mo) dispensed by FDA-registered, PCAB-accredited pharmacies.

Visit WeightCare ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$399/mo
Tirzepatide
$499/mo (15 mg dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh WeightCare against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because WeightCare dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value35/100
Dose & formulation62/100
Clinical oversight55/100
Labs & monitoring54/100
Fulfillment72/100
Contract terms41/100

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

Where it loses points

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose
  • FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Patients prioritizing pharmacy quality standards (PCAB) with coaching support.

Ranked #524 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Weightless Medical LLC dba WeightCare in February 2026. See the FDA warning-letter database.

Visit WeightCare ↗

Closest here

The rankings grading nearest WeightCare — the realistic shortlist.

Mochi Health#521

Obesity medicine telehealth provider offering aggressively priced compounded GLP-1 programs.

PRIMO Health Partners#522

PRIMO Health Partners is a telehealth practice offering virtual weight-loss consults with clinicians who prescribe GLP-1 medications, including semaglutide and tirzepatide.

VivioMD#523

Telehealth wellness provider that does not currently offer GLP-1 medications.

Brello Health#525

Telehealth wellness platform offering GLP-1 weight management.

Remedy Meds#526

Telehealth provider offering compounded semaglutide and tirzepatide programs.

VigorMeds#527

VigorMeds (Vigormeds LLC) is a multi-service telehealth platform offering provider-guided GLP-1 weight management alongside anti-aging, ED, and hair-loss care.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect WeightCare's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on WeightCare's site. Not medical advice; see our disclosure.

← Back to the scorecard